CHF Solutions Announces First Patient Enrolled in the ULTRA-Peds Registry

NEXT STORY
Corbus Pharmaceuticals Announces Completion of Enrollment in NIH-Sponsored Phase 2 Study of Lenabasum for Treatment of Systemic Lupus Erythematosus (SLE)
PREV STORY
Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to Optimize Cancer Immunotherapy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Moleculin Announces Patient Recruitment Begins in Annamycin Clinical Trial In Poland

Received European approval to ship Annamycin into Poland to start treating patients HOUSTON, Jan. ...

author_avatar
NASDAQ Market News

OSE Immunotherapeutics Receives IDMC Approval to Continue “Atalante 1” Phase 3 NSCLC Clinical Trial of Tedopi®

Trial in Non-Small Cell Lung Cancer (NSCLC) Patients After Immune Checkpoint Inhibitor FailureCheckpoint Inhibitor ...

author_avatar
NASDAQ Market News

Optomap® Scanning for Eye Health at Primary Eyecare and Optical of Meridian

MERIDIAN, Miss., Dec. 18, 2016 (GLOBE NEWSWIRE) -- Optometrists at Primary Eyecare and Optical ...

author_avatar
NASDAQ Market News